Angiogenesis in diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Seminars in Nephrology

• Publication date

  2007-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.SEMNEPHROL.2007.01.007PMID 17418685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Salutary Effect of Pigment Epithelium–Derived Factor in Diabetic Nephropathy

  2006cited by this paper
• Podocyte Injury Underlies the Glomerulopathy of Dahl Salt-Hypertensive Rats and Is Reversed by Aldosterone Blocker

  2006cited by this paper
• Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.

  2006cited by this paper
• Advanced glycation end products: sparking the development of diabetic vascular injury.

  2006cited by this paper
• Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.

  2006cited by this paper
• Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice.

  2006cited by this paper
• Glomerular injury is exacerbated in diabetic integrin α1-null mice

  2006cited by this paper
• A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.

  2006cited by this paper
• Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.

  2006cited by this paper
• Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling.

  2006cited by this paper
• VEGF and Angiopoietin‐1 Stimulate Different Angiogenic Phenotypes That Combine to Enhance Functional Neovascularization in Adult Tissue

  2006cited by this paper
• Biology of vascular endothelial growth factors

  2006cited by this paper
• Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.

  2006cited by this paper
• Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes

  2006cited by this paper
• Therapeutic potential of angiostatin in diabetic nephropathy.

  2006cited by this paper
• Reduced Expression of Vascular Endothelial Growth Factor Paralleled With the Increased Angiostatin Expression Resulting From the Upregulated Activities of Matrix Metalloproteinase-2 and -9 in Human Type 2 Diabetic Arterial Vasculature

  2006cited by this paper
• Hydrogen peroxide induces vascular permeability via regulation of vascular endothelial growth factor.

  2006cited by this paper
• Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

  2006cited by this paper
• Angiogenesis--a new target for future therapy.

  2006cited by this paper
• Glomerular injury is exacerbated in diabetic integrin alpha1-null mice.

  2006cited by this paper
• Update on endogenous inhibitors of angiogenesis.

  2006cited by this paper
• VEGF receptor signalling ? in control of vascular function

  2006cited by this paper
• Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy.

  2005cited by this paper
• A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy

  2005cited by this paper
• Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.

  2005cited by this paper
• Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

  2005cited by this paper
• Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.

  2005cited by this paper
• Inhibition by advanced glycation end products (AGEs) of pigment epithelium-derived factor (PEDF) gene expression in microvascular endothelial cells.

  2005cited by this paper
• Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy.

  2005cited by this paper
• Angiogenesis: a curse or cure?

  2005cited by this paper
• Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.

  2005cited by this paper
• The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism

  2005cited by this paper
• Extracellular matrix and the development of disease: The role of its components in cancer progression

  2005cited by this paper
• Angiopoietin-2 Causes Inflammation in Vivo by Promoting Vascular Leakage

  2005cited by this paper
• Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy.

  2005cited by this paper
• Inhibition of Vascular Endothelial Growth Factor (VEGF) Does Not Affect Early Renal Changes in a Rat Model of Lean Type 2 Diabetes

  2005cited by this paper
• Suppression of renin-angiotensin system attenuates hepatocarcinogenesis via angiogenesis inhibition in rats.

  2005cited by this paper
• Antiproliferative efficacy of angiotensin II receptor blockers in prostate cancer.

  2005cited by this paper
• Angiotensin II stimulates α3(IV) collagen production in mouse podocytes via TGF-β and VEGF signalling: implications for diabetic glomerulopathy

  2005cited by this paper
• Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties.

  2004cited by this paper
• From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines.

  2004cited by this paper
• Pathogenesis of Diabetic Nephropathy

  2004cited by this paper
• Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix

  2004cited by this paper
• Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

  2004cited by this paper
• Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes.

  2004cited by this paper
• The role of VEGF-A in glomerular development and function

  2004cited by this paper
• Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy.

  2004cited by this paper
• The effect of angiostatin on vascular leakage and VEGF expression in rat retina

  2004cited by this paper
• Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice.

  2004cited by this paper
• Angiopoietins: microvascular modulators with potential roles in glomerular pathophysiology.

  2003cited by this paper
• Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.

  2003cited by this paper
• Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.

  2003cited by this paper
• Role of advanced glycation end products in diabetic nephropathy.

  2003cited by this paper
• Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor.

  2002cited by this paper
• Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.

  2002cited by this paper
• Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.

  2002cited by this paper
• Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium–derived factor

  2002cited by this paper
• Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

  2002cited by this paper
• Advanced Glycation End Product-induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor and Monocyte Chemoattractant Protein-1 in Human-cultured Mesangial Cells*

  2002cited by this paper
• Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

  2001cited by this paper
• Hydrogen peroxide is a novel inducer of connective tissue growth factor.

  2001cited by this paper
• Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells.

  2001cited by this paper
• Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

  2001cited by this paper
• Angiopoietin growth factors and Tie receptor tyrosine kinases in renal vascular development

  2001cited by this paper
• The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor.

  2001cited by this paper
• Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.

  2000cited by this paper
• Role of vascular endothelial growth factor in diabetic vascular complications.

  2000cited by this paper
• Angiopoietin-1 protects the adult vasculature against plasma leakage

  2000cited by this paper
• Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization.

  2000cited by this paper
• Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.

  1999cited by this paper
• Neovascularization at the vascular pole region in diabetic glomerulopathy.

  1999cited by this paper
• Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

  1999cited by this paper
• Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.

  1999cited by this paper
• Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest.

  1998cited by this paper
• Advanced Glycation End Products-driven Angiogenesis in Vitro

  1997cited by this paper
• In Vitro Kinetic Studies of Formation of Antigenic Advanced Glycation End Products (AGEs)

  1997cited by this paper
• Glomerular endothelial cells in culture express and secrete vascular endothelial growth factor.

  1994cited by this paper
• The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes

  1993cited by this paper
• Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family.

  1993cited by this paper
• J Am Soc Nephrol 12: 993–1000, 2001 Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes

  year unknowncited by this paper

• Angiogenic biomaterials for diabetic wound healing: A review

  2026cites this paper
• Can diabetic peripheral neuropathy predict lacunar stroke in patients with diabetes?

  2025cites this paper
• Tie2 activator 4E2 ameliorates diabetic nephropathy and synergizes with dapagliflozin in a mouse model

  2025cites this paper
• Endothelial cell-targeting aptamer-empowered exosomes accelerate wound healing by promoting specialized angiogenesis in type 1 diabetic mice

  2025cites this paper
• IFN-γ, SCF, MIP1b and IL-16 Were Associated with Risk of Diabetic Nephropathy: A Mendelian Randomization Study

  2024cites this paper
• Unlocking the potential of flavonoid-infused drug delivery systems for diabetic wound healing with a mechanistic exploration

  2024cites this paper
• The peripheral corticotropin releasing factor family's role in vasculitis.

  2024cites this paper
• Engineered keratin/bFGF hydrogel to promote diabetic wound healing in rats.

  2024cites this paper
• Plasma leucine-rich α-2-glycoprotein 1 – a novel marker of diabetic kidney disease in children and adolescents with type 1 diabetes mellitus?

  2023cites this paper
• Enhancing angiogenesis: Innovative drug delivery systems to facilitate diabetic wound healing.

  2023cites this paper
• Anti-angiogenesis and anti-inflammatory effects of Moringa oleifera leaf extract in the early stages of streptozotocin-induced diabetic nephropathy in rats

  2022cites this paper
• Antioxidant and Anti-inflammatory Properties of Resveratrol in Diabetic Nephropathy: A Systematic Review and Meta-analysis of Animal Studies

  2022influential citation
• Combination CTLA-4 immunoglobulin treatment and ultrasound microbubble-mediated exposure improve renal function in a rat model of diabetic nephropathy

  2021cites this paper
• Three-dimensional remodeling of functional cerebrovascular architecture and gliovascular unit in leptin receptor-deficient mice

  2021cites this paper
• Gold nanoparticles as a promising treatment for diabetes and its complications: Current and future potentials

  2021cites this paper
• Effect of Lisinopril and Verapamil on Angiopoietin 2 and Endostatin in Hypertensive Diabetic Patients with Nephropathy: A Randomized Trial

  2021cites this paper
• Evaluation of serum endocan as a marker of diabetic nephropathy

  2021cites this paper
• Vascular endothelial growth factor expression in diabetic nephropathy; a clinico-pathological study

  2020cites this paper
• Thrombospondin-4 increases with the severity of peripheral arterial disease and is associated with diabetes

  2019cites this paper
• High glucose exposure promotes proliferation and in vivo network formation of adipose-tissue-derived microvascular fragments.

  2019cites this paper
• Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy

  2019cites this paper
• The potential use of Endostatin and Angiopoietin-2 as valuable biomarkers for the prediction of Diabetic Nephropathy in Type 2 Diabetes Mellitus

  2019influential citation
• COMPARISON OF THE EFFECT OF EIGHT WEEKS OF MODERATE CONTINUOUS AND SEVER INTERVAL TRAINING ON CARDIAC ANGIOGENESIS IN WISTAR MALE DIABETIC RATS

  2019cites this paper
• NEPHROPATHIC AND DIABETIC NEPHROPATHIC EVALUATION VIA EPIGENETICAL MODIFICATION

  2019cites this paper
• New potentials for 3‐hydroxy‐3‐methyl‐glutaryl‐coenzymeA reductase inhibitors: Possible applications in retarding diabetic complications

  2019cites this paper
• A bigenic mouse model of FSGS reveals perturbed pathways in podocytes, mesangial cells and endothelial cells

  2019cites this paper
• CoQ10-loaded liposomes combined with UTMD prevented early nephropathy of diabetic rats

  2018cites this paper
• Evaluation of endocan and endoglin levels in chronic kidney disease due to diabetes mellitus

  2018cites this paper
• Therapeutic effects of CTLA-4-Ig on diabetic nephropathy in type 2 diabetes mellitus rats ascribed to protection of CTLA-4-Ig on podocytes

  2018cites this paper
• Diphlorethohydroxycarmalol Isolated from Ishige okamurae Represses High Glucose-Induced Angiogenesis In Vitro and In Vivo

  2018cites this paper
• Plasma Leucine-Rich &agr;-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus

  2017cites this paper
• Local and systemic angiogenic and antiangiogenic response in rats after 70 % hepatectomy

  2017cites this paper
• Urinary Haptoglobin Predicts Rapid Renal Function Decline in Asians With Type 2 Diabetes and Early Kidney Disease.

  2016cites this paper
• ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy

  2016cites this paper
• Age-Related Macular Degeneration and Vision Impairment

  2016cites this paper
• Finding a Link Between the TRPV4 Ion Channel and Angiogenesis: A potential Therapeutic Target for Ischemic Heart Disease

  2016cites this paper
• New thiazolidinediones affect endothelial cell activation and angiogenesis.

  2016cites this paper
• Nigella sativa oil and thymoquinone ameliorate albuminuria and renal extracellular matrix accumulation in the experimental diabetic rats.

  2016cites this paper
• Toxic stress, inflammation and symptomatology of chronic complications in diabetes.

  2015cites this paper
• Pathogenic pathways are activated in each major cell type of the glomerulus in the Cd2ap mutant mouse model of focal segmental glomerulosclerosis

  2015cites this paper
• Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways

  2014cites this paper
• Inflammation: Therapeutic Targets for Diabetic Neuropathy

  2014cites this paper
• Anthocyanins in corn: a wealth of genes for human health

  2014cites this paper
• Glycation: the angiogenic paradox in aging and age-related disorders and diseases.

  2014cites this paper
• Anthocyanin-Rich Purple Corn Extract Inhibit Diabetes-Associated Glomerular Angiogenesis

  2013cites this paper
• SENSORY NEURON INSULIN SIGNALING AND ITS ROLE IN DIABETIC NEUROPATHY

  2013cites this paper
• The Effects of Anti-Inflammatory and Anti-Angiogenic DNA Vaccination on Diabetic Nephropathy in Rats

  2012cites this paper
• Diabetes in an Undergraduate Class

  2012cites this paper
• Role of lipotoxicity in endothelial dysfunction.

  2012cites this paper
• Contrast ultrasound and targeted microbubbles: diagnostic and therapeutic applications in progressive diabetic nephropathy.

  2012cites this paper
• Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease

  2011cites this paper
• Connective Tissue Growth Factor (CTGF/CCN2) Mediates Angiogenic Effect of S1P in Human Dermal Microvascular Endothelial Cells

  2011cites this paper
• Diabetic neuropathy: cellular mechanisms as therapeutic targets

  2011cites this paper
• Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease

  2011cites this paper
• Metabolic syndrome: aggression control mechanisms gone out of control.

  2010cites this paper
• Gene Expression Programs of Mouse Endothelial Cells in Kidney Development and Disease

  2010cites this paper
• Angiogenesis in the kidney: a new therapeutic target?

  2009cites this paper
• Do adenosine receptors offer new therapeutic options for diabetic nephropathy?

  2009cites this paper
• Differential proteomic analysis of isolated glomeruli from two murine nephropathy models at early stages of glomerulosclerosis

  2008cites this paper